Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 5918-5925, Vol. 73, No. 7
Department of Neuropharmacology,
Received 27 January 1999/Accepted 26 March 1999
The outcome of viral infections is dependent on the amount of
tissue destruction caused either by direct lysis of infected cells
and/or by immunopathology resulting from the immune response to the
virus. We investigated whether induction of tolerance to only one viral
protein could reduce immunopathology caused by nonlytic lymphocytic
choriomeningitis virus (LCMV) in perforin-deficient hosts. Earlier
studies had shown that LCMV infection results in aplastic anemia and
death in most of these mice and that this is associated with bone
marrow infiltration by antiviral cytotoxic T lymphocytes (CTL) that
secrete inflammatory cytokines. We report here that perforin-deficient
mice exhibit severe immunopathology in multiple organs that is
characterized by infiltration of anti-LCMV CTL that secrete large
amounts of gamma interferon (IFN-
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Thymic Tolerance to Only One Viral Protein Reduces Lymphocytic
Choriomeningitis Virus-Induced Immunopathology and Increases
Survival in Perforin-Deficient Mice
) and tumor necrosis factor alpha
(TNF-
). Importantly, this immunopathology is significantly reduced
and long-term survival of LCMV infection is increased in
perforin-deficient mice expressing LCMV nucleoprotein (NP) in the
thymus (and therefore deleting most of their LCMV-NP CTL) compared to
the situation in thymus nonexpressors. This is due to the selective
reduction of NP-specific CTL responses and their inflammatory-cytokine
(IFN-
and TNF-
) secretion and to a lack of pathogenetically
relevant compensatory responses to other viral proteins. Thus,
"selective reduction" of the antiviral immune response to only one
viral protein can significantly reduce inflammatory immunopathology and
might be a therapeutic possibility for certain nonlytic infections.
*
Corresponding author. Mailing address: Department of
Neuropharmacology, Division of Virology, IMM6, The Scripps Research
Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037. Phone:
(619) 784-9602. Fax: (619) 784-9981. E-mail:
matthias{at}scripps.edu.
Publication 11705-NP from the Division of Virology, Department of
Neuropharmacology, The Scripps Research Institute.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»